Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 371 - 9
Studies of Plasmodium vivax gene expression are complicated by the lack of in vitro culture system and the difficulties associated with studying clinical...
GENETIC DIVERSITY | FORMS | INFECTIONS | COMMITMENT | FALCIPARUM | PACKAGE | MULTIDISCIPLINARY SCIENCES | MALARIA | EXPRESSION | Cell Cycle - genetics | Multigene Family | Genes, Protozoan - genetics | Humans | Plasmodium vivax - genetics | Male | Plasmodium falciparum - drug effects | Trophozoites - genetics | RNA, Messenger - metabolism | Trophozoites - drug effects | Chloroquine - pharmacology | Genes, Protozoan - drug effects | Plasmodium vivax - pathogenicity | Plasmodium falciparum - genetics | Female | Malaria, Falciparum - drug therapy | Plasmodium vivax - drug effects | Transcriptome - drug effects | Antimalarials - pharmacology | Gene Expression Regulation - drug effects | Malaria, Vivax - drug therapy | Genome, Protozoan - drug effects | Genome, Protozoan - genetics | Malaria - drug therapy | Cell Cycle - drug effects | Vector-borne diseases | Trophozoites | Malaria | Genes | Chloroquine | Infections | Gametocytes | Parasites | Gene expression
GENETIC DIVERSITY | FORMS | INFECTIONS | COMMITMENT | FALCIPARUM | PACKAGE | MULTIDISCIPLINARY SCIENCES | MALARIA | EXPRESSION | Cell Cycle - genetics | Multigene Family | Genes, Protozoan - genetics | Humans | Plasmodium vivax - genetics | Male | Plasmodium falciparum - drug effects | Trophozoites - genetics | RNA, Messenger - metabolism | Trophozoites - drug effects | Chloroquine - pharmacology | Genes, Protozoan - drug effects | Plasmodium vivax - pathogenicity | Plasmodium falciparum - genetics | Female | Malaria, Falciparum - drug therapy | Plasmodium vivax - drug effects | Transcriptome - drug effects | Antimalarials - pharmacology | Gene Expression Regulation - drug effects | Malaria, Vivax - drug therapy | Genome, Protozoan - drug effects | Genome, Protozoan - genetics | Malaria - drug therapy | Cell Cycle - drug effects | Vector-borne diseases | Trophozoites | Malaria | Genes | Chloroquine | Infections | Gametocytes | Parasites | Gene expression
Journal Article
Scientific Reports, ISSN 2045-2322, 04/2016, Volume 6, Issue 1, p. 23603
DNA of malaria parasites, Plasmodium falciparum, is subjected to extraordinary high levels of genotoxic insults during its complex life cycle within both the...
OXIDATIVE STRESS | BASE EXCISION-REPAIR | ARTEMISININ RESISTANCE | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | DOUBLE-STRAND BREAKS | TOXOPLASMA-GONDII | MISMATCH-REPAIR | HOMOLOGOUS RECOMBINATION | RESISTANT PLASMODIUM-FALCIPARUM | SACCHAROMYCES-CEREVISIAE | Transcription, Genetic - drug effects | Genes, Protozoan | Gene Expression Profiling | DNA Repair - genetics | Plasmodium falciparum - drug effects | Protozoan Proteins - genetics | DNA Breaks, Double-Stranded | Artemisinins - pharmacology | Histone Code - drug effects | Protein Processing, Post-Translational - drug effects | DNA, Protozoan - drug effects | Plasmodium falciparum - genetics | Acetylation | Chromatin - drug effects | Hydroxamic Acids - pharmacology | Chromatin - ultrastructure | Drug Resistance, Multiple - genetics | Protozoan Proteins - biosynthesis | Antimalarials - pharmacology | Gene Expression Regulation - drug effects | Phenotype | Animals | DNA, Protozoan - genetics | DNA Damage | Chromatin - genetics | Methyl Methanesulfonate - toxicity | Malaria | Transcription | DNA damage | Genotoxicity | Artemisinin | Genomes | Parasites | DNA repair | Antimalarial agents | Deoxyribonucleic acid--DNA | DNA sequencing | Life cycles
OXIDATIVE STRESS | BASE EXCISION-REPAIR | ARTEMISININ RESISTANCE | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | DOUBLE-STRAND BREAKS | TOXOPLASMA-GONDII | MISMATCH-REPAIR | HOMOLOGOUS RECOMBINATION | RESISTANT PLASMODIUM-FALCIPARUM | SACCHAROMYCES-CEREVISIAE | Transcription, Genetic - drug effects | Genes, Protozoan | Gene Expression Profiling | DNA Repair - genetics | Plasmodium falciparum - drug effects | Protozoan Proteins - genetics | DNA Breaks, Double-Stranded | Artemisinins - pharmacology | Histone Code - drug effects | Protein Processing, Post-Translational - drug effects | DNA, Protozoan - drug effects | Plasmodium falciparum - genetics | Acetylation | Chromatin - drug effects | Hydroxamic Acids - pharmacology | Chromatin - ultrastructure | Drug Resistance, Multiple - genetics | Protozoan Proteins - biosynthesis | Antimalarials - pharmacology | Gene Expression Regulation - drug effects | Phenotype | Animals | DNA, Protozoan - genetics | DNA Damage | Chromatin - genetics | Methyl Methanesulfonate - toxicity | Malaria | Transcription | DNA damage | Genotoxicity | Artemisinin | Genomes | Parasites | DNA repair | Antimalarial agents | Deoxyribonucleic acid--DNA | DNA sequencing | Life cycles
Journal Article
PLoS Genetics, ISSN 1553-7390, 02/2013, Volume 9, Issue 2, p. e1003293
Malaria parasites elude eradication attempts both within the human host and across nations. At the individual level, parasites evade the host immune responses...
VARIANT ANTIGEN | MUTATION-RATES | CYTOCHROME-B | ANTIMALARIAL-DRUGS | VAR GENE | GENETICS & HEREDITY | RESISTANCE | CHROMOSOMES | DNA-SEQUENCING DATA | MALARIA PARASITES | ECTOPIC RECOMBINATION | Malaria, Falciparum - genetics | Drug Resistance, Multiple - genetics | Antigens - drug effects | Drug Resistance, Multiple - drug effects | Humans | Host-Parasite Interactions - immunology | Plasmodium falciparum - drug effects | Plasmodium falciparum - immunology | Mitosis - genetics | Host-Parasite Interactions - genetics | Cytochromes b - genetics | Multidrug Resistance-Associated Proteins - immunology | Plasmodium falciparum - genetics | Malaria, Falciparum - immunology | Multidrug Resistance-Associated Proteins - genetics | Antigenic Variation - drug effects | Genome, Protozoan - drug effects | High-Throughput Nucleotide Sequencing | Atovaquone - administration & dosage | Antigenic Variation - genetics | Multidrug Resistance-Associated Proteins - metabolism | Antigens - genetics | Evolution, Molecular | Plasmodium falciparum | Microbial genetics | Antigens | Physiological aspects | Evolutionary genetics | Genetic aspects | Research | Health aspects | Mutation | Parasites | Malaria | Genes | Genomics
VARIANT ANTIGEN | MUTATION-RATES | CYTOCHROME-B | ANTIMALARIAL-DRUGS | VAR GENE | GENETICS & HEREDITY | RESISTANCE | CHROMOSOMES | DNA-SEQUENCING DATA | MALARIA PARASITES | ECTOPIC RECOMBINATION | Malaria, Falciparum - genetics | Drug Resistance, Multiple - genetics | Antigens - drug effects | Drug Resistance, Multiple - drug effects | Humans | Host-Parasite Interactions - immunology | Plasmodium falciparum - drug effects | Plasmodium falciparum - immunology | Mitosis - genetics | Host-Parasite Interactions - genetics | Cytochromes b - genetics | Multidrug Resistance-Associated Proteins - immunology | Plasmodium falciparum - genetics | Malaria, Falciparum - immunology | Multidrug Resistance-Associated Proteins - genetics | Antigenic Variation - drug effects | Genome, Protozoan - drug effects | High-Throughput Nucleotide Sequencing | Atovaquone - administration & dosage | Antigenic Variation - genetics | Multidrug Resistance-Associated Proteins - metabolism | Antigens - genetics | Evolution, Molecular | Plasmodium falciparum | Microbial genetics | Antigens | Physiological aspects | Evolutionary genetics | Genetic aspects | Research | Health aspects | Mutation | Parasites | Malaria | Genes | Genomics
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, p. e0129165
Proteasomes are intracellular complexes that control selective protein degradation in organisms ranging from Archaea to higher eukaryotes. These structures...
TRYPANOSOMA-BRUCEI | COLD-EXPOSURE | INTRACELLULAR-LOCALIZATION | PLASMODIUM-FALCIPARUM | MULTIDISCIPLINARY SCIENCES | GENE FAMILY | TOXOPLASMA-GONDII | ENTAMOEBA-HISTOLYTICA | S PROTEASOME | PATHOGEN TRICHOMONAS-VAGINALIS | PROTOZOAN PARASITE | Endoplasmic Reticulum - metabolism | Molecular Sequence Data | Tritrichomonas foetus - growth & development | Phylogeny | Tritrichomonas foetus - genetics | Protozoan Proteins - genetics | Endoplasmic Reticulum - ultrastructure | Protein Subunits - metabolism | Protozoan Proteins - metabolism | Acetylcysteine - analogs & derivatives | Endoplasmic Reticulum - drug effects | Life Cycle Stages - drug effects | Protein Subunits - genetics | Amino Acid Sequence | Microscopy, Electron, Transmission | Microscopy, Electron, Scanning | Flagella - ultrastructure | Blotting, Western | Proteasome Endopeptidase Complex - genetics | Sequence Homology, Amino Acid | Flagella - metabolism | Cell Cycle | Cysteine Proteinase Inhibitors - pharmacology | Acetylcysteine - pharmacology | Spores, Protozoan - metabolism | Protozoan Proteins - ultrastructure | Protein Subunits - antagonists & inhibitors | Proteasome Endopeptidase Complex - metabolism | Proteasome Endopeptidase Complex - classification | Microscopy, Fluorescence | Spores, Protozoan - drug effects | Spores, Protozoan - ultrastructure | Tritrichomonas foetus - metabolism | Ubiquitin | Proteolysis | Proteases | Analysis | Genomics | Cell cycle | Genomes | Transformation | Membranes | Serine | Differentiation (biology) | Homeostasis | Homology | Labelling | Parasites | Cytosol | Gene sequencing | Proteins | Eukaryotes | Lactacystin | Inhibition | Catalysis | Bioinformatics | Fractionation | Peptidase | Archaea | Fetuses | Gene expression | Electron microscopy | Cell differentiation | Proteasome inhibitors | Substrates | Cysts | Microscopy | Proteasomes | Immunofluorescence | Endoplasmic reticulum | Apoptosis
TRYPANOSOMA-BRUCEI | COLD-EXPOSURE | INTRACELLULAR-LOCALIZATION | PLASMODIUM-FALCIPARUM | MULTIDISCIPLINARY SCIENCES | GENE FAMILY | TOXOPLASMA-GONDII | ENTAMOEBA-HISTOLYTICA | S PROTEASOME | PATHOGEN TRICHOMONAS-VAGINALIS | PROTOZOAN PARASITE | Endoplasmic Reticulum - metabolism | Molecular Sequence Data | Tritrichomonas foetus - growth & development | Phylogeny | Tritrichomonas foetus - genetics | Protozoan Proteins - genetics | Endoplasmic Reticulum - ultrastructure | Protein Subunits - metabolism | Protozoan Proteins - metabolism | Acetylcysteine - analogs & derivatives | Endoplasmic Reticulum - drug effects | Life Cycle Stages - drug effects | Protein Subunits - genetics | Amino Acid Sequence | Microscopy, Electron, Transmission | Microscopy, Electron, Scanning | Flagella - ultrastructure | Blotting, Western | Proteasome Endopeptidase Complex - genetics | Sequence Homology, Amino Acid | Flagella - metabolism | Cell Cycle | Cysteine Proteinase Inhibitors - pharmacology | Acetylcysteine - pharmacology | Spores, Protozoan - metabolism | Protozoan Proteins - ultrastructure | Protein Subunits - antagonists & inhibitors | Proteasome Endopeptidase Complex - metabolism | Proteasome Endopeptidase Complex - classification | Microscopy, Fluorescence | Spores, Protozoan - drug effects | Spores, Protozoan - ultrastructure | Tritrichomonas foetus - metabolism | Ubiquitin | Proteolysis | Proteases | Analysis | Genomics | Cell cycle | Genomes | Transformation | Membranes | Serine | Differentiation (biology) | Homeostasis | Homology | Labelling | Parasites | Cytosol | Gene sequencing | Proteins | Eukaryotes | Lactacystin | Inhibition | Catalysis | Bioinformatics | Fractionation | Peptidase | Archaea | Fetuses | Gene expression | Electron microscopy | Cell differentiation | Proteasome inhibitors | Substrates | Cysts | Microscopy | Proteasomes | Immunofluorescence | Endoplasmic reticulum | Apoptosis
Journal Article
FEBS Letters, ISSN 0014-5793, 2006, Volume 580, Issue 22, pp. 5185 - 5188
RNA interference (RNAi) is an RNA degradation process that involves short, double-stranded RNAs (dsRNA) as sequence specificity factors. The natural function...
Red blood cell | MicroRNA | RNA interference | Malaria | TRYPANOSOMA-BRUCEI | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICRORNAS | malaria | red blood cell | CELL BIOLOGY | GENOMICS | BIOPHYSICS | PLASMODIUM-FALCIPARUM | GROWTH | microRNA | INTERFERENCE | CYCLE | RNA, Protozoan - genetics | Humans | MicroRNAs - metabolism | RNA Stability - drug effects | RNA, Ribosomal - genetics | Cell Differentiation - genetics | Plasmodium falciparum - genetics | Cloning, Molecular | RNA, Transfer - genetics | Plasmodium falciparum - metabolism | RNA, Double-Stranded - metabolism | Malaria - metabolism | Gene Expression Regulation - genetics | RNA, Transfer - metabolism | RNA, Ribosomal - metabolism | RNA Stability - genetics | Gene Expression Regulation - drug effects | RNA, Protozoan - metabolism | Animals | Cell Differentiation - drug effects | Erythrocytes - metabolism | RNA, Double-Stranded - genetics | RNA, Double-Stranded - pharmacology | Genome, Protozoan - drug effects | Genome, Protozoan - genetics | MicroRNAs - genetics | RNA, Small Interfering | Erythrocytes - parasitology | Malaria - genetics | Plasmodium falciparum | Gene expression | Analysis | Transfer RNA
Red blood cell | MicroRNA | RNA interference | Malaria | TRYPANOSOMA-BRUCEI | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICRORNAS | malaria | red blood cell | CELL BIOLOGY | GENOMICS | BIOPHYSICS | PLASMODIUM-FALCIPARUM | GROWTH | microRNA | INTERFERENCE | CYCLE | RNA, Protozoan - genetics | Humans | MicroRNAs - metabolism | RNA Stability - drug effects | RNA, Ribosomal - genetics | Cell Differentiation - genetics | Plasmodium falciparum - genetics | Cloning, Molecular | RNA, Transfer - genetics | Plasmodium falciparum - metabolism | RNA, Double-Stranded - metabolism | Malaria - metabolism | Gene Expression Regulation - genetics | RNA, Transfer - metabolism | RNA, Ribosomal - metabolism | RNA Stability - genetics | Gene Expression Regulation - drug effects | RNA, Protozoan - metabolism | Animals | Cell Differentiation - drug effects | Erythrocytes - metabolism | RNA, Double-Stranded - genetics | RNA, Double-Stranded - pharmacology | Genome, Protozoan - drug effects | Genome, Protozoan - genetics | MicroRNAs - genetics | RNA, Small Interfering | Erythrocytes - parasitology | Malaria - genetics | Plasmodium falciparum | Gene expression | Analysis | Transfer RNA
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 14407 - 8
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects 5-8 million people in Latin America. Although the nitroheterocyclic compound...
RECOMBINATION | IN-VITRO | CRUZI | POSACONAZOLE | TRANSPORTER | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | CHAGAS-DISEASE | RANDOMIZED-TRIAL | MECHANISMS | NIFURTIMOX | Trypanocidal Agents - metabolism | Mutagens - metabolism | Nitroimidazoles - pharmacology | Drug Resistance, Multiple | Mutagens - pharmacology | Trypanosoma cruzi - genetics | Mice, SCID | Trypanosoma cruzi - pathogenicity | Sequence Analysis, DNA | Mutagenesis - drug effects | Triazoles - pharmacology | Nitroimidazoles - metabolism | Animals | Trypanocidal Agents - pharmacology | Chagas Disease - drug therapy | Trypanosoma cruzi - drug effects | Female | Genome, Protozoan - drug effects | Mutation | Disease Models, Animal | Protozoa | Ergosterol | Vigilance | Benznidazole | Cross-resistance | Cloning | Multidrug resistance | Nitroreductase | Genomes | Parasites | Drug resistance | DNA repair | Mitochondria | Metabolites | Mutagenesis | Chagas' disease | Posaconazole | Deoxyribonucleic acid--DNA
RECOMBINATION | IN-VITRO | CRUZI | POSACONAZOLE | TRANSPORTER | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | CHAGAS-DISEASE | RANDOMIZED-TRIAL | MECHANISMS | NIFURTIMOX | Trypanocidal Agents - metabolism | Mutagens - metabolism | Nitroimidazoles - pharmacology | Drug Resistance, Multiple | Mutagens - pharmacology | Trypanosoma cruzi - genetics | Mice, SCID | Trypanosoma cruzi - pathogenicity | Sequence Analysis, DNA | Mutagenesis - drug effects | Triazoles - pharmacology | Nitroimidazoles - metabolism | Animals | Trypanocidal Agents - pharmacology | Chagas Disease - drug therapy | Trypanosoma cruzi - drug effects | Female | Genome, Protozoan - drug effects | Mutation | Disease Models, Animal | Protozoa | Ergosterol | Vigilance | Benznidazole | Cross-resistance | Cloning | Multidrug resistance | Nitroreductase | Genomes | Parasites | Drug resistance | DNA repair | Mitochondria | Metabolites | Mutagenesis | Chagas' disease | Posaconazole | Deoxyribonucleic acid--DNA
Journal Article
Malaria Journal, ISSN 1475-2875, 06/2017, Volume 16, Issue 1, pp. 238 - 12
Background: The current trend of Plasmodium vivax cases imported from Southeast Asia into China has sharply increased recently, especially from the...
Plasmodium vivax | Haplotype-based detecting | Immune evasion | Drug resistance | Positive selection | Invasion | INFECTIOUS DISEASES | SIGNATURES | FALCIPARUM | DRUG-RESISTANCE | ISOLATE | TROPICAL MEDICINE | POPULATION-GENETICS | COMMUNITY | CHINA-MYANMAR BORDER | DIVERSITY | INFECTION | EVOLUTIONARY HISTORY | PARASITOLOGY | Genetic Variation | Genome, Protozoan | Plasmodium vivax - drug effects | Genes, Protozoan - drug effects | China | Plasmodium vivax - genetics | Malaria, Vivax - prevention & control | Drug Resistance | Antimalarials - pharmacology | Genomes | Research | Biological diversity
Plasmodium vivax | Haplotype-based detecting | Immune evasion | Drug resistance | Positive selection | Invasion | INFECTIOUS DISEASES | SIGNATURES | FALCIPARUM | DRUG-RESISTANCE | ISOLATE | TROPICAL MEDICINE | POPULATION-GENETICS | COMMUNITY | CHINA-MYANMAR BORDER | DIVERSITY | INFECTION | EVOLUTIONARY HISTORY | PARASITOLOGY | Genetic Variation | Genome, Protozoan | Plasmodium vivax - drug effects | Genes, Protozoan - drug effects | China | Plasmodium vivax - genetics | Malaria, Vivax - prevention & control | Drug Resistance | Antimalarials - pharmacology | Genomes | Research | Biological diversity
Journal Article
Nature reviews. Microbiology, ISSN 1740-1526, 11/2014, Volume 12, Issue 11, pp. 727 - 727
MALARIA | MICROBIOLOGY | INFECTIONS | Anti-Infective Agents - pharmacology | Genomics | Humans | Plasmodium - genetics | Anti-Infective Agents - therapeutic use | Plasmodium - drug effects | Protozoan Proteins - genetics | Drug Resistance - genetics | Artemisinins - pharmacology | Animals | Artemisinins - therapeutic use | Malaria - parasitology | Genome, Protozoan - drug effects | Genome, Protozoan - genetics | Malaria - drug therapy | Mutation | Genetic research | Genetic aspects | Research | Parasites
Journal Article
BMC Genomics, ISSN 1471-2164, 2007, Volume 8, Issue 1, pp. 7 - 7
Background: In higher eukaryotes DNA methylation regulates important biological functions including silencing of gene expression and protection from adverse...
ANTISENSE INHIBITION | DEOXYRIBONUCLEIC ACIDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CYSTEINE PROTEINASES | GENETICS & HEREDITY | DNA METHYLTRANSFERASE EHMETH | CPG METHYLATION | VIRULENCE | MAMMALIAN-CELLS | HISTONE DEACETYLASE | CYTOSINE METHYLATION | MYZUS-PERSICAE | Virulence - drug effects | Cricetinae | Protozoan Proteins - antagonists & inhibitors | Gene Silencing | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Protozoan Proteins - biosynthesis | Entamoeba histolytica - drug effects | Entamoeba histolytica - pathogenicity | Gene Expression Regulation - drug effects | Azacitidine - pharmacology | Genome, Protozoan - physiology | DNA Methylation | Animals | Genes, Protozoan - drug effects | Microarray Analysis | Genes, Protozoan - physiology | Mesocricetus | Entamoeba histolytica - growth & development | CHO Cells
ANTISENSE INHIBITION | DEOXYRIBONUCLEIC ACIDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CYSTEINE PROTEINASES | GENETICS & HEREDITY | DNA METHYLTRANSFERASE EHMETH | CPG METHYLATION | VIRULENCE | MAMMALIAN-CELLS | HISTONE DEACETYLASE | CYTOSINE METHYLATION | MYZUS-PERSICAE | Virulence - drug effects | Cricetinae | Protozoan Proteins - antagonists & inhibitors | Gene Silencing | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Protozoan Proteins - biosynthesis | Entamoeba histolytica - drug effects | Entamoeba histolytica - pathogenicity | Gene Expression Regulation - drug effects | Azacitidine - pharmacology | Genome, Protozoan - physiology | DNA Methylation | Animals | Genes, Protozoan - drug effects | Microarray Analysis | Genes, Protozoan - physiology | Mesocricetus | Entamoeba histolytica - growth & development | CHO Cells
Journal Article
Microbial Pathogenesis, ISSN 0882-4010, 06/2017, Volume 107, pp. 164 - 174
Leishmaniasis is a group of tropical diseases caused by protozoan parasites of the genus . is a protozoan parasite that causes visceral leishmaniasis, a fatal...
Glutamine synthetase | Kinetics | Localization | Leishmania | MYCOBACTERIUM-TUBERCULOSIS | PROTEIN | MICROBIOLOGY | IMMUNOLOGY | IDENTIFICATION | DRUG TARGETS | STREPTOCOCCUS-SUIS | PREFRONTAL CORTEX | METABOLISM | LIVER | EXPRESSION | GENE EVOLUTION | Temperature | Molecular Weight | Genes, Protozoan - genetics | Genome, Protozoan | Metals | Phosphorylcholine - analogs & derivatives | Protozoan Proteins - drug effects | Protozoan Proteins - genetics | Base Sequence | Phosphorylcholine - antagonists & inhibitors | Protozoan Proteins - chemistry | Enzyme Inhibitors - pharmacology | Gene Expression Regulation | Leishmania donovani - enzymology | Recombinant Proteins - chemistry | Antibodies, Protozoan | Recombinant Proteins - genetics | Enzyme Activation - drug effects | Leishmania donovani - growth & development | Glutamate-Ammonia Ligase - immunology | Sequence Homology, Amino Acid | Glutamate-Ammonia Ligase - drug effects | Recombinant Proteins - immunology | Escherichia coli - genetics | Recombinant Proteins - drug effects | Glutamate-Ammonia Ligase - genetics | Glutamate-Ammonia Ligase - chemistry | DNA, Protozoan - genetics | Leishmaniasis - parasitology | Sequence Analysis | Protozoan Proteins - immunology | Hydrogen-Ion Concentration | Chemotherapy | Ligases | Analysis | Escherichia coli | Genomics | Leishmaniasis | Drug resistance | Glutamate | Glutamine | Cancer | Index Medicus
Glutamine synthetase | Kinetics | Localization | Leishmania | MYCOBACTERIUM-TUBERCULOSIS | PROTEIN | MICROBIOLOGY | IMMUNOLOGY | IDENTIFICATION | DRUG TARGETS | STREPTOCOCCUS-SUIS | PREFRONTAL CORTEX | METABOLISM | LIVER | EXPRESSION | GENE EVOLUTION | Temperature | Molecular Weight | Genes, Protozoan - genetics | Genome, Protozoan | Metals | Phosphorylcholine - analogs & derivatives | Protozoan Proteins - drug effects | Protozoan Proteins - genetics | Base Sequence | Phosphorylcholine - antagonists & inhibitors | Protozoan Proteins - chemistry | Enzyme Inhibitors - pharmacology | Gene Expression Regulation | Leishmania donovani - enzymology | Recombinant Proteins - chemistry | Antibodies, Protozoan | Recombinant Proteins - genetics | Enzyme Activation - drug effects | Leishmania donovani - growth & development | Glutamate-Ammonia Ligase - immunology | Sequence Homology, Amino Acid | Glutamate-Ammonia Ligase - drug effects | Recombinant Proteins - immunology | Escherichia coli - genetics | Recombinant Proteins - drug effects | Glutamate-Ammonia Ligase - genetics | Glutamate-Ammonia Ligase - chemistry | DNA, Protozoan - genetics | Leishmaniasis - parasitology | Sequence Analysis | Protozoan Proteins - immunology | Hydrogen-Ion Concentration | Chemotherapy | Ligases | Analysis | Escherichia coli | Genomics | Leishmaniasis | Drug resistance | Glutamate | Glutamine | Cancer | Index Medicus
Journal Article
BBA - Proteins and Proteomics, ISSN 1570-9639, 2005, Volume 1754, Issue 1, pp. 151 - 159
Protein kinases represent promising drug targets for a number of human and animal diseases. The recent completion of the sequenced genomes of three...
Chemotherapy | Trypanosoma | Protein kinase | Leishmania | Cell cycle | PROCYCLIC FORM | CRUZI | cell cycle | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHAGAS-DISEASE | BRUCEI | CYCLIN-DEPENDENT KINASE | chemotherapy | MEXICANA | protein kinase | HISTONE H1 KINASE | MITOTIC CYCLIN | FLAGELLAR-LENGTH | BIOPHYSICS | CELL-CYCLE | Protein Kinases - metabolism | Protein Kinases - genetics | Cyclin-Dependent Kinases - metabolism | Trypanosomatina - growth & development | Trypanosoma cruzi - metabolism | Humans | Leishmania major - drug effects | Leishmania major - genetics | Trypanosoma cruzi - genetics | Life Cycle Stages - genetics | Animals | Trypanosomatina - metabolism | Models, Biological | Leishmania major - metabolism | Trypanosoma cruzi - drug effects | Mitogen-Activated Protein Kinases - genetics | Genome, Protozoan - drug effects | Protein Kinase Inhibitors - pharmacology | Cyclin-Dependent Kinases - genetics | Mitogen-Activated Protein Kinases - metabolism | Tyrosine | Casein | Protein kinases | Analysis | Cancer
Chemotherapy | Trypanosoma | Protein kinase | Leishmania | Cell cycle | PROCYCLIC FORM | CRUZI | cell cycle | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHAGAS-DISEASE | BRUCEI | CYCLIN-DEPENDENT KINASE | chemotherapy | MEXICANA | protein kinase | HISTONE H1 KINASE | MITOTIC CYCLIN | FLAGELLAR-LENGTH | BIOPHYSICS | CELL-CYCLE | Protein Kinases - metabolism | Protein Kinases - genetics | Cyclin-Dependent Kinases - metabolism | Trypanosomatina - growth & development | Trypanosoma cruzi - metabolism | Humans | Leishmania major - drug effects | Leishmania major - genetics | Trypanosoma cruzi - genetics | Life Cycle Stages - genetics | Animals | Trypanosomatina - metabolism | Models, Biological | Leishmania major - metabolism | Trypanosoma cruzi - drug effects | Mitogen-Activated Protein Kinases - genetics | Genome, Protozoan - drug effects | Protein Kinase Inhibitors - pharmacology | Cyclin-Dependent Kinases - genetics | Mitogen-Activated Protein Kinases - metabolism | Tyrosine | Casein | Protein kinases | Analysis | Cancer
Journal Article
Advances in Parasitology, ISSN 0065-308X, 2011, Volume 77, pp. 141 - 173
Cryptosporidium is an important genus of parasitic protozoa of humans and other vertebrates and is a major cause of intestinal disease globally. Unlike many...
Cryptosporidium | Drug targets | Transcriptomics | Essentiality | Genomics | CELL-FREE CULTURE | IN-VITRO | INFLAMMATORY-BOWEL-DISEASE | CHRONIC DIARRHEA | PLASMODIUM-FALCIPARUM | PARVUM INFECTION | WHOLE GENOME AMPLIFICATION | RATIONAL DRUG DESIGN | HUMAN-IMMUNODEFICIENCY-VIRUS | OF-THE-LITERATURE | PARASITOLOGY | Cryptosporidium parvum - growth & development | Spores, Protozoan - growth & development | Cryptosporidiosis - diagnosis | Humans | Transcriptome | Biomedical Research - trends | Cryptosporidiosis - drug therapy | Cryptosporidiosis - parasitology | Cryptosporidium parvum - genetics | Protozoan Proteins - genetics | Antiprotozoal Agents - pharmacology | Cryptosporidium - growth & development | Animals | Cryptosporidium parvum - drug effects | Protozoan Proteins - metabolism | Cryptosporidium - genetics | Cryptosporidiosis - prevention & control | Cryptosporidium - drug effects |
Cryptosporidium | Drug targets | Transcriptomics | Essentiality | Genomics | CELL-FREE CULTURE | IN-VITRO | INFLAMMATORY-BOWEL-DISEASE | CHRONIC DIARRHEA | PLASMODIUM-FALCIPARUM | PARVUM INFECTION | WHOLE GENOME AMPLIFICATION | RATIONAL DRUG DESIGN | HUMAN-IMMUNODEFICIENCY-VIRUS | OF-THE-LITERATURE | PARASITOLOGY | Cryptosporidium parvum - growth & development | Spores, Protozoan - growth & development | Cryptosporidiosis - diagnosis | Humans | Transcriptome | Biomedical Research - trends | Cryptosporidiosis - drug therapy | Cryptosporidiosis - parasitology | Cryptosporidium parvum - genetics | Protozoan Proteins - genetics | Antiprotozoal Agents - pharmacology | Cryptosporidium - growth & development | Animals | Cryptosporidium parvum - drug effects | Protozoan Proteins - metabolism | Cryptosporidium - genetics | Cryptosporidiosis - prevention & control | Cryptosporidium - drug effects |